Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery
Ulinastatin is well known to inhibit the activity of polymorphonuclear leukocyte elastase (PMNE). The PMNE concentration correlates with the activities of coagulation and fibrinolysis. The purpose of the present study was to investigate the effects of ulinastatin, a protease inhibitor, on coagulation and fibrinolysis in abdominal surgery.
Thirty patients, aged 40 to 70 years, with American Society of Anesthesiologists (ASA) physical status I or II, scheduled for major abdominal surgery, were enrolled. Anesthesia was induced with midazolam and thiopental, and was maintained with sevoflurane, nitrous oxide in oxygen, and an epidural block. An infusion of ulinastatin, 6000 units·kg−1 in 30 min, was started 1 h after the start of surgery in the ulinastatin group (15 patients). In the control group (15 patients), no protease inhibitors were infused. White blood cell count; platelet count; prothrombin time; activated partial thromboplastin time; and plasma concentrations of PMNE, antithrombin (AT), fibrin/fibrinogen degradation product (FDP), fibrinogen, plasminogen, plasmin-α2 plasmin inhibitor complex (PIC), and thrombin-antithrombin complex (TAT) were measured before, at the end of, and 12 h after surgery.
TAT, PIC, and FDP after surgery were significantly lower in the ulinastatin group than in the control group. AT was decreased in the control group but not in the ulinastatin group, with significant differences between the two groups.
Ulinastatin could inhibit coagulation and fibrinolysis in abdominal surgery.
Key wordsPolymorphonuclear leukocyte elastase Protease inhibitor Ulinastatin Coagulation Fibrinolysis
Unable to display preview. Download preview PDF.
- 1.Nishiyama, T, Hirasaki, A 1994Effect of ulinastatin on the elastase release in multiple injuriesAnesth Res307780Google Scholar
- 4.Sato, Y, Ishikawa, S, Otaki, A, Takahashi, T, Hasegawa, Y, Suzuki, M, Yamagishi, T, Mirishita, Y 2000Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin. Inhibiting cytokines and postoperative organ injuryJpn J Thorac Cardiovasc Surg48428434PubMedGoogle Scholar
- 7.Nishiyama, T, Yokoyama, T, Hanaoka, K 1996Correlations between plasma levels of polymorphonuclear leukocyte elastase and coagulation and fibrinolysis parameters in patients undergoing major abdominal surgeryAnesth Res32369372Google Scholar
- 9.Kawamura, T, Inada, K, Kimura, O, Akasaka, N, Wakusawa, R 1994The inhibitory effects of ulinastatin on the increase of interleukin 8 and 6 during open heart surgeryMasui (Jpn J Anesthesiol)4318181823Google Scholar
- 11.Yoshikawa, T, Murakami, M, Seto, O, Sugino, S, Kondo, M 1987Prevention of endotoxin-induced disseminated intravascular coagulation, and inhibition of endotoxin-induced release of thromboplastin activity from leukocytes by a protease-inhibitor, ulinastatin (in Japanese with English abstract)Masui (Jpn J Anesthesiol)3612811285Google Scholar
- 12.Nishiyama, T, Sato, K, Konishi, H, Seto, K 1991Changes in polymorphonuclear leukocyte elastase activity and other parameters in response to surgical invasion (in Japanese with English abstract)ICU to CCU (Jpn J Int Care Med)1510551061Google Scholar